Biogen
BIIB
1,051 hedge funds and large institutions have $37.2B invested in Biogen in 2020 Q3 according to their latest regulatory filings, with 95 funds opening new positions, 311 increasing their positions, 434 reducing their positions, and 93 closing their positions.
3% more capital invested
Capital invested by funds: $36.3B → $37.2B (+$956M)
2% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 93
0.2% less ownership
Funds ownership: 83.17% → 82.98% (-0.2%)
1% less funds holding
Funds holding: 1,060 → 1,051 (-9)
8% less call options, than puts
Call options by funds: $1.42B | Put options by funds: $1.54B
14% less funds holding in top 10
Funds holding in top 10: 21 → 18 (-3)
28% less repeat investments, than reductions
Existing positions increased: 311 | Existing positions reduced: 434
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$88.3M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$87.9M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$83.8M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$70M |
| 5 |
Millennium Management
New York
|
+$49.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
-$158M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$147M |
| 3 |
D.E. Shaw & Co
New York
|
-$133M |
| 4 |
Goldman Sachs
New York
|
-$126M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$116M |
BIIB Hedge Fund Activity: Q3 2020 in Review
1,051 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2020, worth a combined $37.2B — up 2.6% from $36.3B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new BIIB positions and 93 closed out — a net gain of 2 holders — while 311 added to existing stakes and 434 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $88.3M. The largest seller was Nordea Investment Management, cutting an estimated $158M.
- 1,051 institutional investors held Biogen (BIIB) as of Q3 2020, down from 1,060 in Q2 2020.
- Funds reported $37.2B of Biogen stock for Q3 2020, up 2.6% quarter-over-quarter.
- 95 funds opened new Biogen positions in Q3 2020 and 93 closed out, a net change of +2 holders.
- The largest Biogen buyer in Q3 2020 was Morgan Stanley, an estimated $88.3M added.
- The largest Biogen seller in Q3 2020 was Nordea Investment Management, an estimated $158M sold.
Based on aggregated 13F filings for Q3 2020.